These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
4. In vivo evaluation of risperidone-SAIB in situ system as a sustained release delivery system in rats. Lu Y, Tang X, Cui Y, Zhang Y, Qin F, Lu X. Eur J Pharm Biopharm; 2008 Feb; 68(2):422-9. PubMed ID: 17614267 [Abstract] [Full Text] [Related]
5. [Preparation and evaluation of risperidone-loaded microsphere/sucrose acetate isobutyrate in situ forming complex depot with double diffusion barriers]. Lin X, Tang X, Xu YH, Zhang Y, Zhang Y, He HB. Yao Xue Xue Bao; 2015 Jun; 50(6):775-82. PubMed ID: 26521452 [Abstract] [Full Text] [Related]
6. A Uniform Ultra-Small Microsphere/SAIB Hybrid Depot with Low Burst Release for Long-Term Continuous Drug Release. Lin X, Xu Y, Tang X, Zhang Y, Chen J, Zhang Y, He H, Yang Z. Pharm Res; 2015 Nov; 32(11):3708-21. PubMed ID: 26077999 [Abstract] [Full Text] [Related]
10. A novel in situ forming drug delivery system for controlled parenteral drug delivery. Kranz H, Bodmeier R. Int J Pharm; 2007 Mar 06; 332(1-2):107-14. PubMed ID: 17084049 [Abstract] [Full Text] [Related]
17. Sustained release hGH microsphere formulation produced by a novel supercritical fluid technology: in vivo studies. Jordan F, Naylor A, Kelly CA, Howdle SM, Lewis A, Illum L. J Control Release; 2010 Jan 25; 141(2):153-60. PubMed ID: 19772878 [Abstract] [Full Text] [Related]